Skip to content

A Study of Inhaler Use in the Community

Haphazard and Careless Use of Inhalers, an Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02552472
Enrollment
150
Registered
2015-09-17
Start date
2012-08-31
Completion date
2015-10-31
Last updated
2016-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airways Disease, Asthma, Chronic Obstructive Pulmonary Disease

Keywords

Asthma, Inhaler Use, Adherence, Chronic Obstructive Pulmonary Disease

Brief summary

This is a prospective cohort observational study of inhaler adherence in a community care setting (ie. general practice clinics and pharmacies in the community).

Detailed description

Over a 2-4 week period, consecutive patients with a history of respiratory illness already prescribed a salmeterol/fluticasone Diskus inhaler will be asked to participate in this study. Patients will give informed consent to participate in this study of adherence, which will be assessed with the INCA device. Both clinicians and patients will be fully aware that the device is an acoustic recording device and that both time and technique of inhaler use will be assessed. Once consented, patients will be given an INCA enabled inhaler for 1 month and asked to use it as they normally would and then to return it at the end of one month. The days used and the number of doses used in the study period, as per the dose counter, will also be recorded.

Interventions

None listed

Sponsors

Asthma Society Ireland
CollaboratorUNKNOWN
Irish Thoracic Society
CollaboratorOTHER
GlaxoSmithKline
CollaboratorINDUSTRY
Vitalograph Ireland
CollaboratorUNKNOWN
Health Research Board, Ireland
CollaboratorOTHER
Beaumont Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Known history of Respiratory Illness * Prescribed salmeterol/fluticasone Diskus Inhaler

Exclusion criteria

* Unable to understand study protocol * Refusal to sign consent form

Design outcomes

Primary

MeasureTime frameDescription
Inhaler Adherence in TimeOne monthThis is adherence as measured by the INCA device in regards to time of use. This is measured as a rate of use.
Inhaler Technique AdherenceOne MonthThis is adherence measured by the INCA device in regards to technique of use. This is measured as a rate.

Secondary

MeasureTime frameDescription
Gender Measured as Male or FemaleOne MonthRelationship of Gender to Adherence
Education Level Measured as either primary, secondary or tertiary school at recruitment.One MonthRelationship of Education Level (Primary/Secondary/Tertiary) to Adherence
Socio-economic Class Measured as the patient having either Private or Public Health InsuranceOne MonthRelationship of Socio-economic class (Private or Public Health Insurance) to Adherence
Background Respiratory Diagnosis, divided into Asthma, COPD and other.Previous HistoryRelationship of Respiratory Diagnosis (Asthma, COPD, other) to Adherence
Hospitalisation Measured as the number of hospital admissions in the previous yearPrevious YearRelationship of Hospitalisation in the prevoius year to Adherence
Exacerbation Measured as the number of Respiratory Related Exacerbations in the previous yearPrevious YearRelationship of Exacerbation (Respiratory related in the prevoius year) to Adherence
Smoking History measured by three categories: 1. Current Smoker, 2. Ex-Smoker and 3. Never SmokerPrevious HistoryRelationship of Smoking History (Current, Ex-smoker, never smoker) to Adherence
Health Care Use Measured as the number of visits to a General Practitioner in the previous YearPrevious YearRelationship of Health Care Use (Frequency of visit to General Practitioner) to Adherence
Age Measured in Years at time of recruitmentone monthRelationship of Age to Adherence

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026